Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001

Clinical trial NCT05657184 · COMPLETED

Trial details

NCT number: NCT05657184
Sponsor: Regend Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2021-07-19
Primary completion: 2023-06-09
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.